
Lantern Pharma Advances Rare Pediatric Brain Cancer Treatment Using AI Platform
Lantern Pharma is preparing a clinical trial targeting rare pediatric brain cancers using its AI-powered RADR platform following positive FDA feedback, potentially offering new hope for children with devastating central nervous system tumors.
Read full story


























